Investing in earlier and better cancer diagnostics can make expensive oncology therapeutics more relevant or unnecessary.

“I used to complain for so much of my career about the fact that Diagnostics just didn't get the same investment that Therapeutics got because the return on investment just fundamentally different like you know fundamentally different um between the two domains and yet as clinicians like we need the Diagnostics we can't even we can't even think about Therapeutics until we you know well that's that's the irony of it right is that people talk about oh we'd really love to lower healthare costs yeah you need earlier and better Diagnostics like it's just it's just such a no-brainer that you could you know it's I think it's wise to be upset about the cost of oncology Therapeutics that are adding no value but you spend a tenth of that on the Diagnostics you make that problem irrelevant”

“you need earlier and better Diagnostics yeah right like it's just it's just such a no-brainer that you could you know it's I think it's wise to be upset about the cost of oncology Therapeutics that are adding no value but you spend a tenth of that on the Diagnostics you make that problem irrelevant”